20 March 2019 - - US-based biotechnology company Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has completed enrollment in two Phase 2 studies, the company said.
The Phase 2 study of EDP-938 in RSV is a randomised, double-blind, placebo-co...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 March 2019 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has submitted an Investigational New Drug application to the US Food and Drug Administration for an adaptive Phase 2/3 trial with the potential to serve as a pivotal registratio...
20 March 2019 - - US-based cancer diagnostics specialist laboratory CSI Laboratories has added the newly approved Ventana PD-L1 (SP142) Assay as a companion diagnostic test for use in selecting triple-negative breast cancer patients for Tencentriq (a...
20 March 2019 - - US-based clinical-stage biopharmaceutical company Cold Genesys, Inc has closed a USD 22m Series C preferred stock financing, the company said.
New investors participated in the round, including lead investor, ORI Health...
New investors participated in the round, including lead investor, ORI Health...
20 March 2019 - - US-based biopharmaceutical company Aimmune Therapeutics, Inc.'s (NASDAQ: AIMT) Biologics License Application for AR101 has been accepted for review by the US Food and Drug Administration.
Aimmune is developing AR10...
Aimmune is developing AR10...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe